# Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

> **NCT00163501** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 600 (—)

## Conditions studied

- Perennial Allergic Rhinitis
- Allergic Rhinitis
- Hay Fever

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT00163501
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 600 (—)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163501, "Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00163501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*